XML 43 R32.htm IDEA: XBRL DOCUMENT v3.8.0.1
Stock-Based Compensation (Tables)
 9 Months Ended
Sep. 30, 2017
Disclosure of Compensation Related Costs, Share-based Payments [Abstract]  
Stock Based Compensation Activity
The activity related to the Company’s restricted stock units (“RSUs”) consisted of (in thousands of shares):
 
 
Time-Based RSUs
 
Performance-Based and Market-Based RSUs
 
 
Number of Shares
 
Weighted
Average Grant Date
Fair Value
 
Number of Shares
 
Weighted
Average Grant Date
Fair Value
Outstanding at January 1, 2017 (a)
878

 
$
34.83

 
923

 
$
34.11

 
Granted
915

 
35.32

 
572

 
35.21

 
Vested (b)
(470
)
 
37.11

 
(146
)
 
36.55

 
Forfeited/expired
(92
)
 
32.53

 
(304
)
 
38.73

Outstanding at September 30, 2017 (c)
1,231

 
$
34.50

 
1,045

 
$
33.03

__________
(a) 
Reflects the maximum number of stock units assuming achievement of all time-, performance- and market-vesting criteria and does not include those for non-employee directors. The weighted-average fair value of time-based RSUs, and performance-based and market-based RSUs granted during the nine months ended September 30, 2016 was $25.92 and $23.33, respectively.
(b) 
The total grant date fair value of RSUs vested during the nine months ended September 30, 2017 and 2016 was $23 million and $27 million, respectively.
(c) 
The Company assumes 0.1 million of performance-based and market-based RSUs outstanding awards will vest over time with weighted average grate date fair value of $36.64. The Company’s outstanding time-based RSUs, and performance-based and market-based RSUs expected to vest had aggregate intrinsic values of $47 million and $4 million, respectively. Aggregate unrecognized compensation expense related to time-based RSUs, and performance-based and market-based RSUs amounted to $40 million and will be recognized over a weighted average vesting period of 1.3 years.
Summary Of Share Based Compensation Shares Authorized Under Stock Option Plans By Exercise Price Range
The stock option activity consisted of (in thousands of shares): 
 
 
Number of Options
 
Weighted Average Exercise Price
 
Aggregate Intrinsic Value (in millions)
 
Weighted Average Remaining Contractual Term (years)
Outstanding at January 1, 2017
810

 
$
2.91

 
$
27

 
2.3
 
Granted
—

 
—

 
—

 
 
 
Exercised
(14
)
 
0.79

 
—

 
 
 
Forfeited/expired
—

 
—

 
—

 
 
Outstanding and exercisable at September 30, 2017
796

 
$
2.95

 
$
28

 
1.5